What is Cogent Biosciences Inc (COGT) stock price today?

Cogent Biosciences Inc (COGT) currently trades at $35.87 per share. The stock has a market capitalization of $6.29B and a P/E ratio of —x.

Is COGT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Cogent Biosciences Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -4.00.

Is Cogent Biosciences Inc financially healthy?

Cogent Biosciences Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -4.00 places it in the distress.

COGT

Cogent Biosciences Inc

NASDAQ: COGT · HEALTHCARE · BIOTECHNOLOGY

$35.87

-1.29% today

Updated 2026-04-29

Market cap

$6.29B

P/E ratio

—

P/S ratio

861.15x

EPS (TTM)

$-2.16

Dividend yield

—

52W range

$5 – $44

Volume

2.1M

Market cap

$6.29B

P/E ratio

—

P/S ratio

861.15x

EPS (TTM)

$-2.16

Dividend yield

—

52W range

$5 – $44

Volume

2.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

4.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-4.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$54.17

+51.02%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -4.00 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-79.92M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-132.64M	$-192.41M	$-255.86M	$-328.94M	$-102.49M
EPS	—	—	—	—	$-2.16
Free cash flow	$-125.50M	$-156.42M	$-208.36M	$-266.00M	$-79.92M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
COGT	$6.29B	23	3.7	3.0	5.0	4.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Cogent Biosciences Inc trades at $35.87. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -4.00, it sits in the distress.

Frequently asked questions

What is Cogent Biosciences Inc's stock price?

Cogent Biosciences Inc (COGT) trades at $35.87.

Is Cogent Biosciences Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Cogent Biosciences Inc (COGT)?

The analyst target price is $54.17, representing +51.0% upside from the current price of $35.87.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-4.00 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio861.15x

ROE-73.70%

Beta0.47

50D MA$36.63

200D MA$26.88

Shares out0.17B

Float0.15B

Short ratio—

Avg volume2.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

COGT vs LLY →COGT vs JNJ →COGT vs ABBV →Stock screener →